Uluslararası Yayınlar

1. Korun N, Ascı C, Duman H, Yılmazlar T, Tuncel E, Erturk E.: Total thyroidectomy or lobectomy in benign nodular disease of the thyroid. British Journal of Surgery, 82:417-419, 1996.

2. Erturk E, Tuncel E, Yercı O, Gursoy N, Imamoglu S, Korun N, Arınık A.: Retrospective analysis of thyroid cancers. Journal of Environmental Pathology, Toxicology and Oncology, 15(2-4): 245-249, 1996.

3. Erturk E, Jaffe C, Barkan A.: Evaluation of the integrity of hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. The Journal of Clinical Endocrinology & Metabolism 83(7): 2350-2354, 1998.

4. Erturk E, Tuncel E. Polycystic disease and serum leptin levels. Fertil&steril 80 (4): 1068-1070, 2003.

5. Tuncel E, Erturk E, Ersoy C, Kıyıcı S, Duran C, Kuru N, Imamoglu S. Physical activity alters urinary albumin/creatinine ratio in type 1 diabetic patients. JSSM 3:49-54, 2004.

6. Ersoy C, Imamoglu C, Budak F, Tuncel E, Erturk E, Oral B. Effect of amlodipine on insulin resistance & tumor necrosis factor- alpha levels in hypertensive obese type 2 diabetic patients. Indian J Me Res 120: 481-488, 2004

7. Erturk E, Kuru N, Tuncel E, Savcı V, Ersoy C, Imamoglu S. Serum leptin levels correlate with obesity but not with hyperinsulinism in polycytic ovary syndrome. Fertil & Steril 82 (5): 1364-1368, 2004.

8. Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C, Imamoglu S. Outcome of surgery for acromegaly performed by different surgeons: Importance of surgical experience. Pituitary 8 (2): 93-97, 2005.

9. Erturk E, Keskın M, Ersoy C, Kalelı T, Imamoglu S, Fılız G. Metacarpal brown tumor in secondary hyperparathyroidism due to vitamin D deficiency. JBJS. 87 (6): 1363-1366, 2005.

10. Ersoy C, Imamoglu S, Tuncel E, Erturk E, Ercan I. Comparison of the factors that influence obesity prevalance in three district municipalities of the same city with different socioeconomical status: a survey analysis in an urban Turkish population. Preventive  Medicine (40) 181-188, 2005

11. Duran C, Ersoy C, Bolca N, Kıyıcı S, Yalcınkaya U, Erturk E, Tuncel E, Imamoglu S. Brown tumors of the maxillary sinus and patella in a patient with primary hyperparathyroidism. The Endocrinologist.15:351-354, 2005

12. Kıyıcı S, Erturk E, Budak F, Ersoy C, Tuncel E, Duran C, Oral B, Sıgırcı D, Imamoglu S. Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy. Arch Med Res 37:998-1003, 2006

13. Altan L, Kurtoglu Z, Yalçınkayay U, Aydınlı U, Erturk E. Brown tumor of the sacral spine in a patient with low-back pain. Rheumatol Int 28: 77-81, 2007.

14. Unal O, Erturk E, Ozkan H, Kıyıcı S, Guclu M, Ersoy, C, Yener F, Imamoglu S. Effect of levothyroxine treatment on QT dispersion in patients with subclinical hypothyroidism. Endocr Practice 13: 711-715, 2007.

15. Ersoy C, Imamoglu S, Erturk E, Tuncel E, Ercan I. Determination and comparison of the factors leading to overweight and obesity in an urban population. AJCI 1: 78-87, 2007.

16. Duran C, Ersoy C, Tuncel E, Kıyıcı S, Selımoglu H, Ozkaya G, Oz O, Guclu M, Erturk E, Imamoglu S. Combination of single usage of fenofibrate and rosiglitasone in the treatment of type 2 diabetic subjects with hyperlipidemia. AJCI 1:18-24, 2007.

17. Oz Gul O, Ersoy C, Gul CB, Guclu M, Ibanoglu MS, Cangur S, Kiyici S, Cander S, Unal OK, Erturk E, Tuncel E, Imamoglu S. The Relationship Between Minor Alterations in Thyroid Function in Euthyroid Patients and Obesity. J Endocrinol Invest. 2008;31(3):211-5.

18. Ersoy C, Kıyıcı S, Budak F, Oral B, Guclu M, Duran C, Selimoglu H, Erturk E, Tuncel E, Imamoglu S. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Diabetes Res Clin Pract. 2008;81(1):56-60.

19. Duran C, Edıger D, Ersoy C, Coskun Nf, Selımoglu H, Ercan I, Kıyıcı S, Guclu M, Saglam Da, Erturk E, Tuncel E, Imamoglu S. Frequency of atopy and allergic disorders among adults with type 1 diabetes mellitus in the southern Marmara region of Turkey. J Endocrinol Invest 31: 211-215, 2008.

20. Duran C, Tuncel E, Ersoy C, Ercan I, Selimoglu H, Kiyici S, Guclu M, Erturk E, Imamoglu S. The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients. J Endocrinol Invest. 2009;32(1):69-73.

21. Selimoglu H, Duran C, Kiyici S, Guclu M, Ersoy C, Ozkaya G, Erturk E, Tuncel E, Imamoglu S. Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects. Endocrine. 2009;36(2):299-304.

22. Kiyici S, Ersoy C, Oz Gul O, Sarandol E, Demirci M, Tuncel E, Sigirli D, Erturk E, Imamoglu S. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy. Exp Clin Endocrinol Diabetes. 2009;117(8):386-90.

23. Kiyici S, Ersoy C, Kaderli A, Fazlioglu M, Budak F, Duran C, Gul Oo, Sigirli D, Baran I, Tuncel E, Erturk E, Imamoglu S. Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients. Diabetes Res Clin Pract. 2009;86(1):44-50.

24. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010;33(4):234-8.

25. Kiyici S, Gul OO, Baskan EB, Hacioglu S, Budak F, Erturk E, Imamoglu S. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 2010;35(6):603-7.

26. Guclu M, Lin L, Erturk E, Achermann JC, Cangul H. Puberty, stress, and sudden death. Lancet. 2010 30;376(9751):1512.

27. Kiyici S, Cander S, Oz Gul O, Sigirli D, Kaan Unal O, Duran C, Saraydaroglu O, Ersoy C, Tuncel E, Erturk E, Imamoglu S. Preoperative parathyroid hormone levels are correlated with parathyroid adenoma volume and bone mineral density but not serum calcium levels.Minerva Endocrinol. 2011;36(2):123-8.

28. Öz Ö, Kıyıcı S, Ersoy C, Cander S, Yorulmaz H, Gül CB, Ünal OK, Sarandol E, Kırhan E, Sığırlı D, Ertürk E, Tuncel E, Imamoğlu S. Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.Diabetes Res Clin Pract. 2011;94(2):212-6.

29. Cander S, Ertürk E, Karkucak M, Oz Gül O, Görükmez O, Yakut T, Unal OK, Ersoy C, Tuncel E, Imamoğlu S. Effect of cycline D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma.Gene. 2012 1;509(1):158-63.

30. Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database. Endocrine. 2014;47(1):198-205.

31. Cander S, Dizdar OS, Oz Gul O, Guclu M, Unal OK, Tuncel E, Erturk E, Imamoglu S, Ersoy C. Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center. Prim Care Diabetes. 2014;8(3):256-64.

32. Cander S, Karkucak M, Gul OO, Sag SO, Yakut T, Ersoy C, Tuncel E, Erturk E. Association between p16(CDKN2A) C540G polymorphism and tumor behavior in prolactinoma: A single-center study. Biomed Rep. 2014;2(4):589-595.

33. Cander S, Gül ÖÖ, Ertürk E, Tuncel E, Ersoy C. Prolactin levels and gender are associated with tumour behaviour in prolactinomas but Ki-67 index is not. Endokrynol Pol. 2014;65(3):210-6.

34. Gul CB, Oz Gul O, Cander S, Eroglu A, Hartavi M, Keni N, Bayindir A, Ersoy C, Erturk E, Tuncel E, Imamoğlu Ş. Relationship between glycemic control, microalbuminuria and cognitive functions in elderly type 2 diabetic patients. Ren Fail. 2014;36(8):1258-62.

 

İçerik site ziyaretçilerini bilgilendirmeye yöneliktir. Sitede ki bilgiler tanı, tedavi amacı ile kullanılamaz. Sitedeki bilgilerin yanlış anlaşılması veya kullanılması nedeniyle doğabilecek tıbbi veya yasal problemlerden dolayı site yapımcıları sorumlu tutulamaz.